Home Aurora Research Institute Milwaukee Health System Aurora Health Care Launched Leukemia Clinical Trials

Milwaukee Health System Aurora Health Care Launched Leukemia Clinical Trials

222
0

Milwaukee Business Journal reports Aurora Research Institute  has launched two new trials for leukemia patients. It is hoped that this breakthrough will change treatment options for patients with leukemia. Aurora Research Institute’s anticancer drug called ibrutinib is being mobilized for the treating of chronic lymphocytic leukemia (CLL).  According to principal investigator Dr. Rubina Quamar, “CLL is the most common leukemia in adults in Western countries.”

Read more about ibrutinib from the source story below.  Ibrutinib  is owned by AbbVie. Aurora Healthcare is a not-for-profit healthcare system based in Milwaukee, WI. It serves eastern Wisconsin. The  system has 15 hospitals  with more than 150 clinics and 70 pharmacies. The system includes 32,000 employees including 1,800 employed physicians. Its clinical trials are managed through the Aurora Research Institute.

Lead Research/Investigator

Dr. Rubina Quamar, Aurora Healthcare

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.